Spackman Equities Group Inc. (TSXV: SQG) (the "Company" or "SEGI") has entered into an advisory agreement (the "Agreement") ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.

Dot Bardarson, a well-known Alaska artist from Seward, has won many awards and commissions for her work and has long served as an arts advocate. Among her honors are the 2019 Alaska Governor’s ...

In the HER2-low population, treatment with trastuzumab deruxtecan reduced the risk of disease progression or death by 38% compared with chemotherapy. The Food and Drug Administration (FDA ...

When is the Ark 2 release date? Ever since the Ark 2 announcement at The Game Awards 2020, we’ve been looking forward to learning more about the upcoming dinosaur-themed survival game.

There is a commercial access agreement for olaparib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

The Nintendo Switch has been revealed, with more to come April 2. Here's what's confirmed and what we're still guessing at. I started with CNET reviewing laptops in 2009. Now I explore wearable ...

If breast cancer is diagnosed at an early stage, it has a higher chance of being cured. Therefore, it is important that you get tests done at regular intervals as it can help in early diagnosis of ...

DELAFIELD, Wis. — A Delafield woman has picked up her sister’s mission to help those battling cancer. Candice Strong says they did not realize how life-changing a cancer diagnosis would be for ...

The FDA has expanded the label for the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody. This enables the identification of patients with hormone receptor (HR)-positive, HER2-ultralow ...

There is a simple discount patient access scheme for elacestrant. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...